Šalis: Malta
kalba: anglų
Šaltinis: Medicines Authority
PHENYLALANINE; ARGININE; ASPARTIC ACID; ALANINE; THREONINE; VALINE; GLUTAMIC ACID; GLYCINE; ISOLEUCINE; L-LYSINE; L-METHIONINE; L-TRYPTOPHAN; L-TYROSINE; SERINE; L-CYSTEINE; LEUCINE; L-HISTIDINE; PROLINE
Fresenius Kabi Limited
B05BA01
PHENYLALANINE; ARGININE; ASPARTIC ACID; ALANINE; THREONINE; VALINE; GLUTAMIC ACID; GLYCINE; ISOLEUCINE; L-LYSINE; L-METHIONINE;
SOLUTION FOR INFUSION
PHENYLALANINE 7.9 g/l; ARGININE 11.3 g/l; ASPARTIC ACID 3.4 g/l; ALANINE 16 g/l; THREONINE 5.6 g/l; VALINE 7.3 g/l; GLUTAMIC ACID 5.6 g/l; GLYCINE 7.9 g/l; ISOLEUCINE 5.6 g/l; L-LYSINE 9 g/l; L-METHIONINE 5.6 g/l; L-TRYPTOPHAN 1.9 g/l; L-TYROSINE 230 mg/l; SERINE 4.5 g/l; L-CYSTEINE 560 mg/g; LEUCINE 7.9 g/l; L-HISTIDINE 6.8 g/l; PROLINE 6.8 g/l
POM
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
Authorised
2007-09-11
M095710/04 GB V002 Schwarz Product Name: Type of Packaging: Dosage: Territory: Pharma-Code (Laetus) EAN Code: - Font: Smallest Size: 2-D-Matrix Code Material number: Colour: 1. Draft 30.11.2015, 19:15 1. Corr 02.12.2015, 13:15 2. Corr 15.12.2015, 17:00 3. Corr 17.10.2016, 10:30 4. Corr 27.10.2016, 09:30 Variable Data: Operator: PETER SCHAFFER +43(0) 664-9116508 VAMIN 18 EF GB LEAFLET - M095710/04 GB - M095710/04 GB Antique Olive 8 Dimension: 180 X 294 MM M095710/04 GB PACKAGE LEAFLET: INFORMATION FOR THE USER VAMIN ® 18 ELECTROLYTE - FREE SOLUTION FOR INFUSION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE, BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What is Vamin 18 EF and what it is used for 2. What you need to know before you receive Vamin 18 EF 3. How you are given Vamin 18 EF 4. Possible side effects 5. How to store Vamin 18 EF 6. Contents of the pack and other information 1. WHAT VAMIN 18 EF IS AND WHAT IT IS USED FOR Vamin 18 EF provides nourishment into your blood stream when you cannot eat normally. It provides amino acids, which your body will use to make proteins (to build and repair muscles, organs, and other body structures). Vamin 18 EF is typically mixed with salts, fats, carbohydrates and vitamins, which together provide complete nutritional needs. In this leaflet this solution will be referred to as Vamin 18 EF. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN VAMIN 18 EF DO NOT USE VAMIN 18 EF IF: • a known allergy (hypersensitivity) to Vamin 18 EF or any of the ingredients of Vamin 18 EF mentioned in section 6 (for symptoms of an allergic reaction please refer to section 4). • seriously reduced liver function • reduced kidney function (ureamia) and are not on dialysis or a Perskaitykite visą dokumentą
MT SmPC Vamin 18EF_V002 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Vamin 18 Electrolyte-Free solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION A 1000ml solution for infusion contains: Alanine Arginine Aspartic Acid L-Cysteine/Cystine Glutamic Acid Glycine L-Histidine Isoleucine Leucine L-Lysine L-Methionine Phenylalanine Proline Serine L-Threonine L-Tryptophan L-Tyrosine Valine 16.0 g 11.3 g 3.4 g 560 mg 5.6 g 7.9 g 6.8 g 5.6 g 7.9 g 9.0 g 5.6 g 7.9 g 6.8 g 4.5 g 5.6 g 1.9 g 230 mg 7.3 g For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for infusion Clear, colourless to straw coloured solution of amino acids. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS For the prophylactic or therapeutic treatment of protein depletion, where sufficient enteral feeding is impossible or impracticable. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION MT SmPC Vamin 18EF_V002 Page 2 of 5 Posology_ _ _ _ ADULTS Depending upon patient requirements up to one litre intravenously per 24 hours. Vamin 18 Electrolyte-Free is administered by slow intravenous infusion at approximately 40 drops per minute or slower corresponding to an infusion time of at least eight hours per litre. _ _ ELDERLY Age per se requires no adjustment of the adult dosage. However, caution should be exercised in the “frail” elderly, and indeed in all patients with poor renal, cardiac or liver function, where smaller volumes should be used depending on the individual patient’s requirements and condition. PAEDIATRIC POPULATION Can be administered at the physician’s discretion. An amino acid solution containing larger amounts of cysteine/cystine and tyrosine may be considered more appropriate in infants. Method of administration For intravenous use only. 4.3. CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 Vamin 18 Electrolyte-Free is contraindicated in patients with irreversible liver damage and in severe uraemia when Perskaitykite visą dokumentą